Matrix metalloproteinase polypeptide

Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Hydrolase

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S656000, C514S002600

Reexamination Certificate

active

07070976

ABSTRACT:
The present invention provides genes encoding novel matrix metalloproteinases termed MMP; constructs and recombinant host cells incorporating the genes; the MMP polypeptides encoded by the genes; antibodies to the MMP polypeptides; and methods of making and using all of the foregoing.

REFERENCES:
patent: 4399216 (1983-08-01), Axel et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4879236 (1989-11-01), Smith et al.
patent: 5202231 (1993-04-01), Drmanac et al.
patent: 5521065 (1996-05-01), Whiteley et al.
patent: 5585277 (1996-12-01), Bowie et al.
patent: 5837832 (1998-11-01), Chee et al.
patent: 6399371 (2002-06-01), Falduto et al.
patent: 0 367 566 (1990-05-01), None
patent: 91/09955 (1991-07-01), None
patent: 91/18982 (1991-12-01), None
patent: 92/20808 (1992-11-01), None
patent: 93/11236 (1993-06-01), None
patent: 94/12650 (1994-06-01), None
patent: 95/20652 (1995-08-01), None
patent: 96/22976 (1996-08-01), None
patent: 97/09433 (1997-03-01), None
patent: 98/37177 (1998-08-01), None
patent: WO 00/18900 (2000-06-01), None
patent: WO 01/16335 (2001-03-01), None
Lohi et al., Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury. J Biol Chem. 2001 Mar. 30;276(13): 10134-44.
UniProt Database Accession No. MM28—Human Oct. 10, 2003 from Lohi et al., Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes . . . J Biol Chem. Mar. 30, 2001;276(13): 10134-44. Alignment with SEQ ID NO.: 6.
McDonagh et al., Production of caseinophosphopeptides (CPPs) from sodium caseinate using a range of commercial protease preparations. International Dairy Journal (1988), 8(1), 39-45.
Ausubel, 1988 Current Protocols in Molecular Biology Chapters 1, 9, 13, and 16 and Appendix 5. John Wiley & Sons, Inc. New York, NY.
Birren et al, 1998 Homo sapiens chromosome 17, clone hRPC. 161—P—9. EMBL Acc# AC006237 alignment with SEQ ID No.: 3.
Akane et al., “Direct Dideoxy Sequencing of Genomic DNA by Ligation-Mediated PCR”,Biotechniques, 1994, vol. 16, pp. 238-241.
Altschul et al., “Basic Local Alignment Search Tool,”J. Mol. Biol., 1990, 215, 403-410.
American Veterinary Medical Association,Report of the American Veterinary Medical Assoc., Panel on Euthanasia,Journal of American Veterinary Medical Assoc., 1993, 202, 229-249.
Anderson, “Human Gene Therapy”,Nature, 1998, Suppl. To vol. 392, No. 3379, pp. 25-30.
Anderson, W. F., “Human gene therapy,”Science, 1992, 256, 808-813.
Aujame et al., “High Affinity Human Antibodies by Phage Display”,Human Antibodies, 1997, vol. 8, No. 4, pp. 155-168.
Ausubel, et al. (Eds.), “Chapter 6, Screening of recombinant DNA libraries,”Current Protocols in Molecular Biology, 1994, John Wiley & Sons, 6.0.1.-6.4.10.
Baindur et al., “Selective fluorescent ligands for pharmacological receptors,”Drug Dev. Res., 1994, 33, 373-398.
Baker et al., “Induction of Acetylcholine Receptor Clustering by Native Polystyrene Beads. Implication of an Endogenous Muscle-derived Signalling System”,J. Cell Sci., 1992, vol. 102, pp. 543-555.
Benoist et al., “In vivosequence requirements of the SV40 early promoter region,”Nature, 1981, 290, 304-310.
Bertilsson, G. et al., “Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction”,Proc. Natl. Acad. Sci. USA, 1998, 95, 12208-12213.
Bosseé , R., et al., “Development of nonseparation binding and functional assays for G protein-coupled receptors for high throughput screening: Pharmacological characterization of the immobilized CCR5 receptor on FlashPlate®,”J. Biomolecular Screening, 1998, 3(4), 285-292.
Bruggemann, M., et al., “Production of human antibody repertoires in transgenic mice,”Curr. Opin. Biotechnol., 1997, 8, 455-458.
Bruggemann, M., et al., “Strategies for expressing human antibody repertoires in transgenic mice,”Immunol. Today, 1996, 17(8), 391-397.
Can, D.E., et al., “Harnessing the Biosynthetic Code: Combinations, Permutations, and Mutations,”Science, Oct. 1998, 282, 63-68.
Capecchi, M. R., “Altering the genome by homologous recombination,”Science, 1989, 244, 1288-1292.
Cheng, L. et al., “Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo”,Circulation, 1998, 98, 2195-2201.
Choo, Y., et al., “Promoter-specific activation of gene expression directed by bacteriophage-selected zinc fingers,”J. Mol. Biol., 1997, 273, 525-532.
Cosman, D., et al., “High Level Stable Expression of Human Interleukin-2 receptors in Mouse Cells Generates only Low Affinity Interleukin-2 Binding Sites,”Mol. Immunol., 1986, 23(9), 935-941.
Cosman, D., et al., “Cloning, sequence and expression of human interleukin-2 receptor,”Nature, 1984, 312, 768-771
Dayoff, inAtlas of Protein Sequence and Structure, 1972, National Biochemical Research Foundation, Washington, D.C., 5, 124.
Deckert, T. et al., “Implications for micro-and macrovascular disease”,Diabetes Care, 1992, 15(9), 1181-1191.
Douglas, A. M., et al., “Direct sequencing of double-stranded PCR products incorporating a chemiluminescent detection procedure,”Biotechniques, 1993, 14, 824-828.
Drmanac, R., et al., “DNA Sequence Determination by Hybridization A Strategy for Efficient Large-Scale Sequencing,”Science, Jun. 1993, 260, 1649-1652.
Drmanac, S., et al., “Accurate sequencing by hybridization for DNA diagnostics and individual genomics,”Nature Biotechnology, 1998, 16, 54-58.
Ebihara, I., et al., “Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus”,Am. J. Kidney Dis., 1998, 32(4), 544-550.
Falk, E. et al., “Coronary plaque disruption”,Circulation, 1995, 92, 657-671.
Fields, S., et al., “A novel genetic system to detect protein-protein interactions,”Nature, 1989, 340, 245-246.
Fields, S., et al., “The two-hybrid system: an assay for protein-protein interactions,”Trends in Genetics, 1994, 10, 286-292.
Fischer, S. G., et al., “DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: Correspondence with melting theory,”Proc. Natl. Acad. Sci. USA, 1983, 80, 1579-1583.
Foote, J., et al., Antibody framework residues affecting the conformation of the hypervariable loops,J. Mol. Biol., 1992, 224, 487-499.
Forough, R. et al., “Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo”,Cir. Res., 1996, 79(4), 812-820.
Frank, K. et al., “Diabetic eye disease: A primary care perspective”,South. Med. J., 1996, 89(5), 463-470.
Friedmann, T., “Progress toward human gene therapy,”Science, 1989, 244, 1275-1281.
Fuster, V. et al., “Acute coronary syndromes; biology”,Lancet, 1999, 353(suppl. II), 5-9.
Gerhardt, C. C., et al., “Functional characteristics of heterologously expressed 5-HT receptors,”Eur. J. Pharmacology, 1997, 334, 1-23.
Gomez, D. et al., “Tissue inhibitors of metalloproteinases: structure, regulation and biological functions”,Eur. J. Cell. Biol., 1997, 74, 111-122.
Greisman, H. A., et al., “A general strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites,”Science, 1997, 275, 657-661.
Harendza, S. et al., “In vitro characterization of the mesangial phenotype in a proliferative glomerulonephritis of the rat”,Nephrol. Dial. Transplant, 1997, 12, 2537-2541.
Henikoff, S., et al., “Amino acid substitution matrices from protein blocks,”

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Matrix metalloproteinase polypeptide does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Matrix metalloproteinase polypeptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Matrix metalloproteinase polypeptide will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3588615

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.